7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Privacy Policy
Close This Panel X
  • Latest News
  • Most Popular
View All | Scroll Down Scroll Up

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Zacks Rank #1 Strong Buys

Analyst Blog

Print
Share

Altera Unveils 20nm Product Plans

by Zacks Equity Research

September 10, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Programmable logic device (PLD) maker Altera Corporation ( ALTR - Analyst Report ) recently revealed several key innovations planned for its next-generation 20-nanometer products.

Based in San Jose, California, the company designs, manufactures, and markets a broad range of high-performance, high-density PLDs such as field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs).
Based on its 20nm products, Altera expects to offer customers a unique integration platform, which combines the hardware programmability of FPGAs with the software flexibility of digital signal processors and microprocessors as well as the efficiencies of application-specific hard intellectual property (IP).
This new node is projected to deliver new levels of performance, bandwidth, integration and power efficiency.
Altera continues to achieve great success for products in the 28-nanonmeter node. Altera believes that opportunities in the 28-nanometer segment is larger than any prior node. Hence, the company continues to explore further in the application-specific integrated circuit (ASIC) and Application-specific standard products (ASSP) markets for PLD.
In the second quarter, Altera registered growth both in the 28nm and 40nm products. 28nm products grew 166% sequentially. 40nm products accounting for 28% of revenue grew 42% sequentially.
Altera continues to benefit from the growth in 65-nm and 40-nm FPGAs as customer designs move from prototyping to production. Altera has a pipeline of 28 nanometer products, which it believes will maintain the growth momentum in the upcoming quarters.
PLD is an integrated circuit that can be programmed to perform complex functions. Logic devices are used to direct signal traffic within a digital system.
Last week, Altera updated its guidance for the third quarter of 2012. Altera expects revenue growth of 2% – 6% on a sequential basis, in line with the guidance provided with the second quarter results. This implies a revenue guidance of $437.5 million – $452.9 million.
Altera continues to see traction in the 28-nanometer node and expects revenue from this node to exceed $20 million in the third quarter. Revenue from 40-nanometer node is also expected to grow sequentially.
We continue to maintain a Neutral recommendation on Altera Corporation. Nevertheless, we have a Zacks #2 Rank on the stock, which translates into a short-term rating of Buy.

Read the full reports :

Email Print Share Rate Pos Rate Neg

Disclosure / Disclaimer Link
Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.
Quick Links

Services

My Account

Resources

Client Support

Follow Us

Facebook

Twitter

Linkedin

RSS

You Tube

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.

Copyright 2013 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.

NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.